When saliva is reduced, these bacteria can grow more easily, increasing the risk of tooth decay, gum inflammation, and bad breath. As for changes in taste perception, the relationship has yet to be clearly defined
Semaglutide, a GLP-1 receptor agonist, slows stomach emptying and reduces appetite, but its mechanism raises legitimate questions about safety during or after diverticular disease
Skin barrier dysfunction and systemic sensitization to allergens through the skin
Of particular concern for patients with diabetes, berberine may potentiate the glucose-lowering effects of antidiabetic medications, including insulin, sulfonylureas, and meglitinides, potentially increasing hypoglycemia risk
Again, I'm not here to tell you what to do or what not to do, but if you have it in mind that peptide therapeutics, because they aren't hormone therapies, are not without their potential risks, you would be wrong
Slower transit produces harder, less frequent stools